- Home
- SOPA vs INM Comparison
SOPA vs INM Comparison
Compare SOPA & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOPA
- INM
- Stock Information
- Founded
- SOPA 2018
- INM 1981
- Country
- SOPA Singapore
- INM Canada
- Employees
- SOPA N/A
- INM N/A
- Industry
- SOPA EDP Services
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- SOPA Technology
- INM Health Care
- Exchange
- SOPA Nasdaq
- INM Nasdaq
- Market Cap
- SOPA 3.8M
- INM 4.5M
- IPO Year
- SOPA 2021
- INM N/A
- Fundamental
- Price
- SOPA $1.29
- INM $2.25
- Analyst Decision
- SOPA Strong Buy
- INM
- Analyst Count
- SOPA 1
- INM 0
- Target Price
- SOPA $15.00
- INM N/A
- AVG Volume (30 Days)
- SOPA 113.2K
- INM 70.4K
- Earning Date
- SOPA 08-13-2025
- INM 09-29-2025
- Dividend Yield
- SOPA N/A
- INM N/A
- EPS Growth
- SOPA N/A
- INM N/A
- EPS
- SOPA N/A
- INM N/A
- Revenue
- SOPA $7,522,939.00
- INM $4,920,990.00
- Revenue This Year
- SOPA N/A
- INM N/A
- Revenue Next Year
- SOPA $45.16
- INM N/A
- P/E Ratio
- SOPA N/A
- INM N/A
- Revenue Growth
- SOPA 0.31
- INM N/A
- 52 Week Low
- SOPA $0.64
- INM $1.72
- 52 Week High
- SOPA $6.75
- INM $15.70
- Technical
- Relative Strength Index (RSI)
- SOPA 51.51
- INM 37.83
- Support Level
- SOPA $1.04
- INM $2.16
- Resistance Level
- SOPA $1.67
- INM $2.30
- Average True Range (ATR)
- SOPA 0.14
- INM 0.10
- MACD
- SOPA 0.02
- INM 0.01
- Stochastic Oscillator
- SOPA 39.68
- INM 22.50
About SOPA Society Pass Incorporated
Society Pass Inc is building an ecosystem of platforms and technology-enabled companies that synergistically work together to transform how consumers and merchants interact with one another in Southeast Asia and South Asia. Through the acquisition of companies and partnerships with entrepreneurs, the company meets the growing demand for services in sectors such as lifestyle, beauty, travel, and food and beverage. The company currently operates in Six reportable operating segments: Online Grocery and Food deliveries, Digital marketing, Online ticketing and reservation, Telecommunications Reseller, e-commerce, and Corporate. The company generates the majority of its revenue from the Digital marketing segment.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.